These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20248526)

  • 41. [Dynamics of antibodies against tularemia following immunization with a live tularemia vaccine].
    Richter J; Vítková V; Stehlík J; Minaríková H
    Cesk Epidemiol Mikrobiol Imunol; 1965 Jul; 14(4):221-4. PubMed ID: 4220875
    [No Abstract]   [Full Text] [Related]  

  • 42. [Time course of the production of immunoglobulins in patients with tularemia].
    Ohara S; Sato T; Homma M
    Nihon Saikingaku Zasshi; 1984 Mar; 39(2):103-6. PubMed ID: 6748218
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS.
    Sandström G; Sjöstedt A; Johansson T; Kuoppa K; Williams JC
    FEMS Microbiol Immunol; 1992 Oct; 5(4):201-10. PubMed ID: 1419118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of an immunochromatographic test for rapid and reliable serodiagnosis of human tularemia and detection of Francisella tularensis-specific antibodies in sera from different mammalian species.
    Splettstoesser W; Guglielmo-Viret V; Seibold E; Thullier P
    J Clin Microbiol; 2010 May; 48(5):1629-34. PubMed ID: 20220165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Natural foci of tularemia on the Wrangel island].
    Podobedova IaS; Demidova TN; Kormilitsyna MI; Meshcheriakova IS
    Med Parazitol (Mosk); 2006; (4):32-4. PubMed ID: 17290906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of human tularemia; isolation of the first occurrence of Pasteurella Tulanrensis in man in Belgium].
    LAKAYE G; GODBILLE M
    Rev Med Liege; 1950 Dec; 5(24):827-8. PubMed ID: 14809038
    [No Abstract]   [Full Text] [Related]  

  • 47. Tularemia in two cats.
    Woods JP; Crystal MA; Morton RJ; Panciera RJ
    J Am Vet Med Assoc; 1998 Jan; 212(1):81-3. PubMed ID: 9426784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Epizootic significance of white-toothed shrews in the natural focus of steppe type tularemia in the Stavropol' region].
    Tikhenko NI; Levchenko BI; Briukhanov AF; Degtiareva LV; Tsygankova RE; Antonenko AD
    Med Parazitol (Mosk); 2001; (2):46-8. PubMed ID: 11702461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outbreaks of tularemia in Turkey.
    Sahin M; Atabay HI; Bicakci Z; Unver A; Otlu S
    Kobe J Med Sci; 2007; 53(1-2):37-42. PubMed ID: 17579300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Laboratory diagnosis and serologic course in patients with tularemia].
    Dueñas AI; Ortega M; Garrote I; de Frutos M; Gutiérrez P; García-Pascual A; Cuervo M; Hernández Novoa B; Bratos MA; Almaraz A; Orduña A; Rodríguez Torres A
    Med Clin (Barc); 2000 Mar; 114(11):407-10. PubMed ID: 10786358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. USE OF FLUORESCENT ANTIBODIES FOR THE RAPID DIAGNOSIS OF INFECTIONS CAUSED BY B. ANTHRACIS AND P. TULARENSIS.
    FRANEK J
    J Hyg Epidemiol Microbiol Immunol; 1965; 9():160-8. PubMed ID: 14345660
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on the pathogenesis and immunity of tularemia. I. The demonstration of a protective antibody in mouse serum.
    PANNELL L; DOWNS CM
    J Infect Dis; 1953; 92(2):195-204. PubMed ID: 13052966
    [No Abstract]   [Full Text] [Related]  

  • 53. Antitularense serum; correlation between protective capacity for white rats and precipitable antibody content.
    FOSHAY L; RUCHMAN I; NICHOLES PS
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():21. PubMed ID: 20248526
    [No Abstract]   [Full Text] [Related]  

  • 54. Antitularense serum; correlation between protective capacity for white rats and precipitable antibody content.
    FOSHAY L; RUCHMAN I; NICHOLES PS
    J Lab Clin Med; 1947 Mar; 32(3):332. PubMed ID: 20289818
    [No Abstract]   [Full Text] [Related]  

  • 55. ANTITULARENSE SERUM: CORRELATION BETWEEN PROTECTIVE CAPACITY FOR WHITE RATS AND PRECIPITABLE ANTIBODY CONTENT.
    Foshay L; Ruchman I; Nicholes PS
    J Clin Invest; 1947 Jul; 26(4):756-60. PubMed ID: 16695467
    [No Abstract]   [Full Text] [Related]  

  • 56. Correlation between protective capacity for white rats and precipitable antibody content of antitularense serums.
    FOSHAY L; RUCHMAN I; NICHOLES PS
    J Bacteriol; 1947 Apr; 53(4):502. PubMed ID: 20342059
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.